Akoya Biosciences Inc (AKYA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | AKYA | AMGN | VRTX | GILD | BMY |
| Company | Akoya Biosciences Inc | Amgen Inc | Vertex Pharmaceutic | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 3.20 | 322.48 | 507.17 | 96.05 | 54.70 |
| High | 3.24 | 328.25 | 519.57 | 97.32 | 54.79 |
| Low | 3.10 | 321.28 | 504.94 | 94.91 | 54.08 |
| Last | 3.12 | 327.32 | 517.42 | 96.59 | 54.33 |
| Change | -0.10 | +5.41 | +14.97 | -1.31 | -0.38 |
| % Change | -3.11% | +1.68% | +2.98% | -1.34% | -0.69% |
| Volume | 28,316 | 802,586 | 614,454 | 4,231,452 | 3,764,327 |
| 20-Day Average Volume | 98,859 | 1,792,685 | 1,081,499 | 5,819,496 | 8,916,293 |
| Previous Close | 3.22 | 321.91 | 502.45 | 97.90 | 54.71 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 2.98 | 319.61 | 483.37 | 89.03 | 53.58 |
| 20-Day Raw Stochastic | 76.25% | 86.89% | 99.95% | 85.41% | 54.01% |
| 20-Day Relative Strength | 55.08% | 54.77% | 65.58% | 75.14% | 56.55% |
| Weighted Alpha | +6.31 | +20.13 | +39.59 | +39.49 | +13.42 |
| Today's Opinion | 32% Buy | 48% Buy | 88% Buy | 100% Buy | 100% Buy |
| Previous Opinion | 32% Buy | 8% Buy | 88% Buy | 100% Buy | 100% Buy |
| Last Month's Opinion | 8% Buy | 40% Buy | 40% Buy | 100% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +13.92% since 11/01/24 | +2.11% since 11/01/24 | +10.15% since 11/01/24 | +7.56% since 11/01/24 | -0.08% since 11/01/24 |
| Low | 2.50 on 11/04/24 | 313.02 on 11/05/24 | 468.77 on 11/04/24 | 89.01 on 11/05/24 | 54.08 on 11/08/24 |
| High | 3.30 on 11/07/24 | 328.25 on 11/08/24 | 518.98 on 11/08/24 | 98.32 on 11/07/24 | 56.80 on 11/06/24 |
| 1-Month | |||||
| %Chg | +0.32% since 10/08/24 | +2.60% since 10/08/24 | +13.08% since 10/08/24 | +12.99% since 10/08/24 | +3.42% since 10/08/24 |
| Low | 2.50 on 11/04/24 | 310.63 on 10/30/24 | 456.16 on 10/09/24 | 84.17 on 10/11/24 | 51.31 on 10/15/24 |
| High | 3.30 on 11/07/24 | 329.17 on 10/11/24 | 518.98 on 11/08/24 | 98.32 on 11/07/24 | 56.80 on 11/06/24 |
| 3-Month | |||||
| %Chg | +48.80% since 08/08/24 | +0.38% since 08/08/24 | +11.37% since 08/08/24 | +27.37% since 08/08/24 | +15.85% since 08/08/24 |
| Low | 2.08 on 08/09/24 | 310.63 on 10/30/24 | 447.70 on 10/07/24 | 72.43 on 08/12/24 | 46.48 on 08/12/24 |
| High | 3.30 on 11/07/24 | 339.17 on 09/23/24 | 518.98 on 11/08/24 | 98.32 on 11/07/24 | 56.80 on 11/06/24 |
| 6-Month | |||||
| %Chg | -24.33% since 05/08/24 | +6.06% since 05/08/24 | +23.91% since 05/08/24 | +48.31% since 05/08/24 | +24.28% since 05/08/24 |
| Low | 1.88 on 05/23/24 | 295.30 on 06/13/24 | 416.03 on 05/09/24 | 62.07 on 05/31/24 | 39.35 on 07/05/24 |
| High | 4.65 on 05/10/24 | 346.85 on 07/25/24 | 518.98 on 11/08/24 | 98.32 on 11/07/24 | 56.80 on 11/06/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 159,387 | 173,037,264 | 129,395,448 | 121,884,712 | 110,961,560 |
| Shares Outstanding, K | 49,499 | 537,533 | 257,529 | 1,244,992 | 2,028,177 |
| Annual Sales | 96,630,000 | 28,190,000,000 | 9,869,200,000 | 27,116,000,000 | 45,006,000,000 |
| Annual Net Income | -63,320,000 | 6,717,000,000 | 3,619,600,000 | 5,665,000,000 | 8,025,000,000 |
| Last Quarter Sales | 23,160,000 | 8,503,000,000 | 2,645,600,000 | 6,954,000,000 | 11,892,000,000 |
| Last Quarter Net Income | -13,150,000 | 2,830,000,000 | -3,593,600,000 | 1,614,000,000 | 1,211,000,000 |
| 60-Month Beta | 1.34 | 0.60 | 0.39 | 0.17 | 0.44 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.27 on 08/05/24 | 5.58 on 10/30/24 | 4.38 on 11/04/24 | 2.02 on 11/06/24 | 1.80 on 10/31/24 |
| Latest Earnings Date | 11/14/24 | 10/30/24 | 11/04/24 | 11/06/24 | 10/31/24 |
| Most Recent Dividend | N/A | 2.250 on 08/16/24 | N/A | 0.770 on 09/13/24 | 0.600 on 10/04/24 |
| Next Ex-Dividends Date | N/A | 11/18/24 | N/A | 12/13/24 | 10/04/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.74 | 0.00 | 20.70 | 47.25 |